The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.
CNBC’s Angelica Peebles and Vertex JournavxPharmaceuticals CEO Reshma Kewalramani join 'Squawk on the Street' to discuss the ...
Vertex Pharmaceuticals’ non-opioid pain medication is up for FDA approval this week. Other drugmakers have found safer ...
Having shown last week that its opioid alternative can reduce post-surgery pain, Tris Pharma is back with another slice of ...